Filter
1886
Filtered Results: 1886
Text search:
Food
and
Drug
Administration
Featured
Recommendations
199
New Publications
557
Language
Document type
No document type
1113
Guidelines
329
Studies & Reports
233
Manuals
91
Strategic & Response Plan
55
Fact sheets
26
Training Material
21
Situation Updates
8
Resource Platforms
3
Infographics
3
Brochures
2
Videos
2
Countries / Regions
India
112
Ethiopia
73
Kenya
67
Nigeria
56
Global
52
Tanzania
49
South Africa
46
Uganda
40
Ghana
38
Liberia
37
Myanmar / Burma
35
Western and Central Europe
34
Sierra Leone
32
Nepal
30
Rwanda
30
Philippines
29
Zambia
29
Bangladesh
23
Latin America and the Carribbean
22
Africa
19
Malawi
18
Eastern Europe
17
Indonesia
15
Namibia
14
Lesotho
13
USA
13
Zimbabwe
12
Russia
12
Colombia
11
Cambodia
11
South Sudan
10
Congo, Democratic Republic of
9
Germany
8
Botswana
8
Ukraine
7
Syria
7
West and Central Africa
7
Middle East and North Africa
7
South–East Asia Region
7
Brazil
7
Eswatini/ Swaziland
7
Mozambique
6
Thailand
5
Cameroon
5
Haiti
5
Eastern Europe and Central Asia
5
Sudan
5
Laos
4
Venezuela
4
Jordan
4
East and Southern Africa
4
Tajikistan
3
Iran
3
Peru
3
Asia
3
Western Pacific Region
3
Paraguay
3
Argentina
3
Papua New Guinea
3
Iraq
3
Somalia
3
Pakistan
3
Timor Leste/ East Timor
2
Turkey
2
Benin
2
Senegal
2
Morocco
2
United Kingdom
2
Vietnam
2
Sri Lanka
2
Yemen
2
Central African Republic
2
Poland
2
Angola
2
Libya
2
Switzerland
1
Mexico
1
El Salvador
1
China
1
Chile
1
Albania
1
Singapore
1
Burkina Faso
1
Afghanistan
1
Qatar
1
Guinea
1
Guinea-Bissau
1
Hungary
1
Lithuania
1
Saudi Arabia
1
North America
1
Turkmenistan
1
Denmark
1
France
1
Maldives
1
Tunisia
1
Portugal
1
Spain
1
Lebanon
1
Moldova
1
Greece
1
Palestine
1
Georgia
1
Mali
1
Bhutan
1
Authors & Publishers
Publication Years
Category
Countries
829
Clinical Guidelines
208
Public Health
85
Women & Child Health
77
Key Resources
46
Pharmacy & Technologies
26
Capacity Building
25
Toolboxes
AMR
139
Mental Health
129
TB
129
COVID-19
124
HIV
118
Pharmacy
90
NTDs
49
Rapid Response
48
Caregiver
44
Ebola
37
NCDs
34
Planetary Health
29
Refugee
26
Conflict
17
Specific Hazards
14
Global Health Education
14
Disability
13
Cholera
10
Natural Hazards
9
Zika
9
Polio
6
Social Ethics
4
Health Financing Toolbox
3
Health Financing
1
The consolidated guidelines are complemented by an operational handbook which is designed to assist with implementation of the WHO recommendations by Member States, technical partners and others who are involved in the management of patients with DR-TB. The WHO Operational Handbook on Tuberculosis, ...
The current trend in AMR in Uganda and globally is rising and calls for immediate action. The 71st UN General Assembly (UNGA), the 68th World Health Assembly, and organizations including the World Health Organization (WHO), the Food and Agriculture Organization (FAO), and the World Organization for ...
Global Tuberculosis Report 2022 Factsheet
recommended
The World Health Organization Global TB Report provides a comprehensive and up-to-date assessment of the TB epidemic, and progress in the response, at global, regional and country levels.
The 2022 edition features data on disease trends and the response to the epidemic from 215 countries and area...
China is one of the major countries for the production and use of antibacterial agents. Antibacterial agents are widely used in healthcare and animal husbandry. It plays a significant role in treating infections and saving patient lives, preventing and treating animal diseases, improving farming ef...
The Pharmacovigilance team in WHO aims to assure the safety of medicines and vaccines by ensuring reliable and timely exchange of information on safety issues, promoting pharmacovigilance activities throughout the Organization and encouraging participation in the WHO Programme for International Drug...
Antimicrobial agents play an indispensable role in animal health and welfare management. At the same time, the need for prudent use is obvious to ensure good food safety outcomes and to manage the potential risk of antimicrobial resistance. The emergence of multi-resistant bacteria is posing challen...
The mandate of the National Tuberculosis Control Programme is to provide leadership and stewardship to accelerate intense and coordinated efforts to reduce the adult TB burden of 290 per 100,000 population recently established in the 2013 National TB Prevalence Survey. Other key challenges are low T...
This Situation Update describes events occurring in Bilin Township, Thaton District during the period between July and October 2017, including healthcare, education, development projects and drug issues.
MSF Essential Drugs - Practical Guidelines 2022
recommended
Practical guide intended for physicians, pharmacists, nurses and medical auxiliaries. This guide is not a dictionary of pharmacological agents. It is a practical manual intended for health professionals, physicians, pharmacists, nurses and health auxiliaries invoved in curative care and drug managem...
An Act to repeal the Dangerous Medicines Act of 1973,to ensure the availability of certain drugs for exclusive medical, scientific and related purposes, while preventing their abuse; to prevent the diversion from lawful trade of controlled chemicals, controlled equipment and controlled materials for...
The guidelines are aimed at clinical professionals directly involved with and responsible for the care of adults with HIV infection, and at community advocates responsible for promoting the best interests and care of HIV-positive adults. They should be read in conjunction with other published BHIVA ...
In the kingdom of Bahrain, the national antibiotic committee will set the framework for the national response to AMR, especially bacterial resistance to antibiotics. It will be aligned with the World Health Organization’s (WHO) Global Action Plan on Antimicrobial Resistance, and with standards and...
Application of a One Health approach .
The present guidance was developed with the support of the WHO Advisory Group on Integrated Surveillance of Antimicrobial Resistance (AGISAR) to assist countries and other stakeholders in the establishment and development of programmes of integrated surveillan...
Of the 50 antibiotics in the pipeline, 32 target WHO priority pathogens but the majority have only limited benefits when compared to existing antibiotics. Two of these are active against the multi-drug resistant Gram-negative bacteria, which are spreading rapidly and require urgent solutions.
Gr...
Antibiotics have been a critical public health tool since the discovery of Penicillin in 1928, saving the lives of millions of people around the world. In developing country like ours, where the burden of treatable disease is very high and access to health facilities and laboratories is difficult, a...
Following the encouraging initial results of the pilot project, the Ministry of Health is committed to increasing access to MDR-TB diagnosis, treatment and care. An expansion plan for the programmatic management of drug-resistant TB has been developed and forms part of the Five Year National Strateg...
These guidelines are based on the 3rd Edition of the WHO Guidelines (Published 2015) World Health Organization’s Guidelines for the treatment of malaria. Additional literature surveys have been undertaken. Factors that were considered in the choice of therapeutic options included effectiveness, sa...
This report provides an update on the key facets of HIV treatment access, including the latest HIV treatment guidelines from World Health Organization (WHO), an overview on pricing for first-line, second-line, and salvage regimens, and a summary of the opportunities for – and threats to – expand...
WHO needs US$2.54 billion to provide life-saving assistance to millions of people around the world facing health emergencies. WHO’s Health Emergency Appeal is a consolidation of WHO’s priorities and financial requirements for 2023 to carry out health interventions in emergency and humanitarian r...
The internationally recognized criteria for diagnosis of neurocysticercosis include a requirement for neuroimaging techniques, such as computerized tomography (CT) and/or magnetic resonance imaging (MRI), ideally supported by serology. These facilities are not available in all settings, especially i...
